131 related articles for article (PubMed ID: 3626713)
1. [Dynamics and significance of immunoglobulin E (IgE) as an immunological parameter in squamous cell carcinomas of the oral cavity and pharynx].
Mayer BA; Enzmann H
Laryngol Rhinol Otol (Stuttg); 1987 Jun; 66(6):316-9. PubMed ID: 3626713
[TBL] [Abstract][Full Text] [Related]
2. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings].
Esser D; Anke S; Roessner A; Freigang B
Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912
[TBL] [Abstract][Full Text] [Related]
3. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
[TBL] [Abstract][Full Text] [Related]
4. [Feasibility of DNA impulse cytophotometry (ICP) in the diagnosis of squamous cell cancers of the oral cavity and oropharynx].
Adler D; Feichter GE; Maier H
Laryngol Rhinol Otol (Stuttg); 1986 Apr; 65(4):187-90. PubMed ID: 3713395
[TBL] [Abstract][Full Text] [Related]
5. [Consumption and value of regular after care by patients with squamous cell carcinomas of the larynx, mouth cavity and pharynx].
Wolfensberger M
HNO; 1988 Jan; 36(1):28-32. PubMed ID: 2832353
[TBL] [Abstract][Full Text] [Related]
6. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
7. The influence of reactivation of the telomerase in tumour tissue on the prognosis of squamous cell carcinomas in the head and neck.
Koscielny S; Eggeling Fv; Dahse R; Fiedler W
J Oral Pathol Med; 2004 Oct; 33(9):538-42. PubMed ID: 15357674
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
Doweck I; Robbins KT; Samant S; Vieira F
World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary treatment of carcinoma of oropharynx and hypopharynx: principles and EORTC studies.
Snow GB
Sonderb Strahlenther Onkol; 1987; 81():127-34. PubMed ID: 3547724
[No Abstract] [Full Text] [Related]
10. [Simultaneous squamous cell carcinomas of the oral cavity and oropharynx].
Ricard AS; Majoufre-Lefebvre C; Demeaux H; Siberchicot F; Zwetyenga N
Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):509-12. PubMed ID: 17881023
[TBL] [Abstract][Full Text] [Related]
11. An update on squamous carcinoma of the oral cavity, oropharynx, and maxillary sinus.
Lubek JE; Clayman L
Oral Maxillofac Surg Clin North Am; 2012 May; 24(2):307-16, x. PubMed ID: 22341511
[TBL] [Abstract][Full Text] [Related]
12. Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynx.
Schuller DE; Grecula JC; Agrawal A; Rhoades CA; Orr DA; Young DC; Malone JP; Merz M
Cancer; 2002 Jun; 94(12):3169-78. PubMed ID: 12115349
[TBL] [Abstract][Full Text] [Related]
13. Management to prevent high-sited recurrence of pharyngo-laryngeal cancers.
Remacle M; Robillard T; Deckers C; Mazy G; Hamoir M; Van de Eeckhaut J
Acta Otorhinolaryngol Belg; 1984; 38(5):464-73. PubMed ID: 6535365
[TBL] [Abstract][Full Text] [Related]
14. [Cancer of the oral cavity and oropharynx in patients under 40 years of age: clinical appearance and treatment results].
Takahara T; Fujitani T; Inoue K; Osamu K; Furuya T; Hattori H
Nihon Jibiinkoka Gakkai Kaiho; 1988 Feb; 91(2):204-9. PubMed ID: 3373371
[No Abstract] [Full Text] [Related]
15. [Clinical aspects in oral, pharyngeal and laryngeal carcinoma--results of an overall Swiss cohort study].
Wolfensberger M; Schmid S; Schatzmann E
Schweiz Med Wochenschr; 1994 Apr; 124(16):678-83. PubMed ID: 8184303
[TBL] [Abstract][Full Text] [Related]
16. Incurable recurrences in patients with oropharyngeal and hypopharyngeal carcinomas.
Wiegand S; Zimmermann AP; Müller HH; Werner JA; Sesterhenn AM
Head Neck; 2014 Feb; 36(2):231-4. PubMed ID: 23766100
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of carcinoma of the oral cavity and the mesopharynx].
Hamann D; Sonnenburg M; Oll U
Radiobiol Radiother (Berl); 1989; 30(3):221-6. PubMed ID: 2772150
[TBL] [Abstract][Full Text] [Related]
18. [Recurrencies in oropharyngeal, hypopharyngeal and supraglottic squamous-cell carcinomas (author's transl)].
Mann W; Laniado K; Kiefer K
Laryngol Rhinol Otol (Stuttg); 1980 Oct; 59(10):652-4. PubMed ID: 7453419
[TBL] [Abstract][Full Text] [Related]
19. [Oro- and hypopharyngeal cancer: the Basle concept of therapy].
Wey W; Hünig R; Roth J; Walther E
Sonderb Strahlenther Onkol; 1987; 81():48-55. PubMed ID: 3824132
[No Abstract] [Full Text] [Related]
20. Recent advances in Oral Oncology 2007: imaging, treatment and treatment outcomes.
Scully C; Bagan JV
Oral Oncol; 2008 Mar; 44(3):211-5. PubMed ID: 18261952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
